Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility study
Frontiers in Physiology · 10.03.2026 · 17
DOI: 10.3389/fphys.2026.1760707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 10.03.2026. Verfasst von Frauke Stascheit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Department of Neurology with Experimental Neurology, Berlin, Germany. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
We conducted an exploratory pilot feasibility study to assess the safety and feasibility of cardiopulmonary exercise testing (CPET) in patients with mild generalized myasthenia gravis (gMG), aiming to determine whether test termination results from systemic exertion or MG-specific neuromuscular fatigability and to evaluate short-term effects on fatigue.
Methods
Nine patients with mild gMG (median age of 58 years, IQR 46.0–66.5) were included in this exploratory feasibility study and underwent a single maximal incremental CPET on a cycle ergometer with breath-by-breath gas exchange analysis and blood lactate measurements. Predefined exertion criteria (EC) included respiratory exchange rate (RER; ≥1.1), ventilatory equivalent for O 2 (EQO 2 ; ≥30), attainment of age-related maximum heart rate (ARMHR), peak blood lactate concentration (>6 mmol·L −1 ), and Borg Scale for Rated Perceived Exertion (RPE; ≥17). Repetitive nerve stimulation (RNS) was performed before and after CPET to assess neuromuscular fatigability. Fatigue was assessed using the Chalder Fatigue Scale (CFS) at baseline and 4 weeks after CPET.
Results
CPET was completed by all participants without adverse events. All reported symptoms resolved within 30 min after exercise termination, and no participant required medical intervention. All participants completed the maximal incremental CPET according to the predefined protocol. Among the predefined EC, 44% of participants achieved an RER ≥1.1, 78% an EQO 2 ≥30, 44% an ARMHR, 67% reached a peak blood lactate concentration >6 mmol·L −1- , and 67% an RPE ≥17. A decremental response in RNS was observed in 78% both before and after CPET. No relevant changes in CFS scores were detected over 4 weeks.
Discussion
CPET appears safe and feasible in mild gMG, with exercise termination primarily driven by systemic exertion rather than MG-specific neuromuscular fatigue. CPET may complement clinical evaluation by supporting individualized training recommendations and the identification of cardiopulmonary limitations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Charité - Universitätsmedizin Berlin, Department of Neurology with Experimental Neurology, Berlin, Germany.
- Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- University Outpatient Clinic for Sports Medicine and Sports Orthopedics, University of Potsdam, Potsdam, Germany.
- Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Institute for Applied Health Promotion and Exercise Medicine (IfAG), Furtwangen University, Furtwangen, Germany.
Zitieren
APA
Stascheit, F., Lauermann, M., Risch, L., Mayer, F., Hoffmann, S., Meisel, A., Roecker, K., & Cassel, M. (2026). Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility study. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1760707
Vancouver
Stascheit F, Lauermann M, Risch L, Mayer F, Hoffmann S, Meisel A, et al. Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility study. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1760707
BibTeX
@article{Stascheit2026,
author = {Stascheit, Frauke and Lauermann, Maximilian and Risch, Lucie and Mayer, Frank and Hoffmann, Sarah and Meisel, Andreas and Roecker, Kai and Cassel, Michael},
title = {Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility study},
journal = {Frontiers in Physiology},
year = {2026},
volume = {17},
doi = {10.3389/fphys.2026.1760707}
}
EUVIMED